VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar Longshot520 (75.79) Submitted: 12/9/2010 11:50:55 AM : Outperform Start Price: $9.14 VVUS Score: +161.93

$1 billion dollar well with no buckets in it...until VVUS and OREX.

Featured Broker Partners


Advertisement